← Back to Search

Game-Based Intervention for HPV Vaccination

N/A
Recruiting
Led By ANGELA CHEN, PhD
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Summary

This trial will study a game-based approach for family members of 11-14 year olds to promote HPV vaccination. The intervention has potential to reduce HPV-associated cancers in youth, with low-cost technology use.

Who is the study for?
This trial is for families with kids aged 11-14 who haven't had their first HPV shot. The child must understand English, and the parent should be over 18, speak English or Spanish, own a smartphone, and agree to participate in study activities and receive texts. Healthcare providers involved need to be over 20 and work at the study sites.
What is being tested?
The trial is testing an innovative game designed to encourage HPV vaccination among youth. It will assess how well this game works in health clinics, its acceptance by families, any changes it brings about regarding vaccinations, and what factors affect its success.
What are the potential side effects?
Since this intervention involves a game-based educational tool rather than a medical treatment or drug, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Child vaccination status (1st & 2nd doses).
Ease of use (intervention arm only)
Intention to vaccinate the child against HPV
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HPV game groupExperimental Treatment1 Intervention
Parent-child dyads receive a HPV game intervention
Group II: Usual careActive Control1 Intervention
Parent-child dyads receive child's usual care

Find a Location

Who is running the clinical trial?

Michigan State UniversityLead Sponsor
193 Previous Clinical Trials
669,104 Total Patients Enrolled
1 Trials studying Vaccine-Preventable Diseases
180 Patients Enrolled for Vaccine-Preventable Diseases
Arizona State UniversityOTHER
294 Previous Clinical Trials
107,299 Total Patients Enrolled
2 Trials studying Vaccine-Preventable Diseases
130 Patients Enrolled for Vaccine-Preventable Diseases
ANGELA CHEN, PhDPrincipal InvestigatorMichigan State University
1 Previous Clinical Trials
180 Total Patients Enrolled
1 Trials studying Vaccine-Preventable Diseases
180 Patients Enrolled for Vaccine-Preventable Diseases
~75 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top